4.8 Article

Forazoline A: Marine-Derived Polyketide with Antifungal In Vivo Efficacy

Journal

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
Volume 53, Issue 43, Pages 11583-11586

Publisher

WILEY-V C H VERLAG GMBH
DOI: 10.1002/anie.201405990

Keywords

antifungal agents; genomics; natural products; NMR spectroscopy; structure elucidation

Funding

  1. University of Wisconsin-Madison School of Pharmacy
  2. NIH, NIGMS [R01 GM092009]
  3. DOE Great Lakes Bioenergy Research Center (DOE BER Office of Science) [DE-FC02-07ER64494]
  4. National Institutes of Health [1R01HG005084-01A1, 1R01M104975-01, R01HG005853]
  5. National Science Foundation [DBI 0953881]
  6. CIFAR Genetic Networks Program
  7. NIH [P41RR02301, P41M66326, RR02781, RR08438]
  8. University of Wisconsin [BIR-9512577, S10RR13790]
  9. NSF [DMB-8415048, OIA-9977486, BIR-9214394]
  10. USDA
  11. [R01 GM104192]

Ask authors/readers for more resources

ForazolineA, a novel antifungal polyketide with invivo efficacy against Candida albicans, was discovered using LCMS-based metabolomics to investigate marine-invertebrate-associated bacteria. ForazolineA had a highly unusual and unprecedented skeleton. Acquisition of C-13-C-13 gCOSY and C-13-N-15 HMQCNMR data provided the direct carbon-carbon and carbon-nitrogen connectivity, respectively. This approach represents the first example of determining direct C-13-N-15 connectivity for a natural product. Using yeast chemical genomics, we propose that forazolineA operated through a new mechanism of action with a phenotypic outcome of disrupting membrane integrity.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available